Viewing StudyNCT05840510



Ignite Creation Date: 2024-05-06 @ 6:57 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05840510
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-21
First Post: 2023-04-12

Brief Title: Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation KRYSTAL -19
Sponsor: Mirati Therapeutics Inc
Organization: Mirati Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Malignant Neoplastic Disease
Solid Tumor Adult
NSCLC
Advanced Cancer
Metastatic Cancer
Keywords:
Name View
ABI-009 View
KRAS View
NSCLC View
Adagrasib View
KRAS G12C View
mTOR View
nab-sirolimus View
Fyarro View